PTEN and thyroid cancer, nonmedullary, 2: Following, the mutation or deletion of the tumor suppressor gene – PTEN (phosphatase and tensin homolog) and PIK3CA transcript (coding the p110α catalytic subunit of PI3K) are the classical genetic alterations that activate the PI3K–AKT pathway in ~10% and 10%–30% of FTC cases, respectively [53,54].